Related Experiment Videos
The future of the management of ischaemic heart disease
1University of Sheffield, Clinical Sciences Centre, Northern General Hospital.
Insights
Basic science offers new hope for tackling ischaemic heart disease, a leading cause of death. Research into plaque stability, restenosis, and organ shortages may lead to better patient treatments.
Area of Science:
- Cardiology
- Basic Science Research
Background:
- Ischaemic heart disease is a leading cause of mortality in Britain, incurring significant healthcare costs.
- Current treatment approaches face limitations, prompting a shift towards fundamental scientific investigation.
Purpose of the Study:
- To explore how basic science can advance understanding and treatment of ischaemic heart disease.
- To address key clinical challenges including coronary plaque stability, restenosis post-angioplasty, and organ transplant limitations.
Main Methods:
- This article synthesizes current knowledge and proposes future research directions at the intersection of basic science and clinical cardiology.
- Focuses on identifying fundamental mechanisms underlying disease progression and treatment failure.
Main Results:
- Basic science research holds potential to resolve uncertainties regarding coronary plaque stability.
- Understanding the mechanisms of restenosis after percutaneous transluminal angioplasty can inform new therapeutic strategies.
- Advances in basic science may offer solutions to the critical shortage of organs for cardiac transplantation.
Conclusions:
- Basic science is crucial for developing novel diagnostic and therapeutic strategies for ischaemic heart disease.
- Addressing plaque instability, restenosis, and organ scarcity through fundamental research is essential for improving patient outcomes.
- A multidisciplinary approach integrating basic science with clinical practice is vital for combating ischaemic heart disease.
Abstract:
Ischaemic heart disease will kill over 150,000 people in the next year in Britain, more than any other single disease process, and cost more than 1.4bn pounds in health care alone. Faced with the continuing problems arising from ischaemic heart disease cardiological clinician scientists are moving from technology based solutions to basic sciences. This article explains how basic science may contribute to new understanding and treatments for patients with ischaemic heart disease. Highlighted are three problems which face any clinical cardiologist on a daily basis and for which basic science may provide solutions: the uncertainty of plaque stability in coronary disease; restenosis after percutaneous transluminal angioplasty; and the shortage of organs for cardiac transplant programmes for patients with heart failure.